From: Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
Univariable analysis | Multivariable analysis (model 1) | Multivariable analysis (model 2) | ||||
---|---|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | |
Age | 0.965 (0.920–1.012) | 0.142 | ||||
Female sex | 1.625 (0.208–12.705) | 0.644 | ||||
Hypertension | 0.955 (0.228–3.995) | 0.949 | ||||
Diabetes mellitus | N/A | > 0.999 | ||||
Mucocutaneous manifestations | 0.709 (0.180–2.792) | 0.623 | ||||
Musculoskeletal manifestations | 1.667 (0.370–7.515) | 0.506 | ||||
Neuropsychiatric manifestations | 0.600 (0.107–3.363) | 0.561 | ||||
Serositis | 1.308 (0.110–15.570) | 0.832 | ||||
Hematologic manifestations | 2.368 (0.544–10.317) | 0.251 | ||||
Positive anti-Sm Ab | 0.400 (0.116–1.376) | 0.146 | ||||
Positive anti-Ro Ab | 0.552 (0.165–1.838) | 0.333 | ||||
Positive anti-La Ab | 1.364 (0.294–6.319) | 0.692 | ||||
Positive anti-U1RNP Aba | 0.286 (0.075–1.086) | 0.066 | ||||
Positive anti-dsDNA Abb | 4.600 (1.207–17.524) | 0.025 | 4.545 (1.107–18.661) | 0.036 | 1.003 (0.999–1.007) | 0.159 |
Positive lupus anticoagulant | 2.000 (0.452–8.841) | 0.361 | ||||
Positive anti-β2 glycoprotein I Ab | 0.433 (0.099–1.900) | 0.267 | ||||
Positive anti-cardiolipin Ab | 1.364 (0.294–6.319) | 0.692 | ||||
Low C3a | 3.818 (0.922–15.808) | 0.065 | ||||
Low C4a | 1.333 (0.406–4.379) | 0.635 | ||||
Albumin level | 0.866 (0.435–1.721) | 0.680 | ||||
Creatinine level | 5.076 (0.446–57.756) | 0.190 | ||||
GFR | 0.988 (0.968–1.009) | 0.273 | ||||
Urine PCR | 1.002 (0.985–1.020) | 0.808 | ||||
Urine RBC of ≥ 5/HPF | 3.929 (1.122–13.755) | 0.032 | 3.326 (0.559–19.795) | 0.187 | 2.402 (0.464–12.428) | 0.296 |
Urine WBC of ≥ 5/HPF | 3.091 (0.895–10.672) | 0.074 | ||||
Urine cast | 4.636 (0.509–42.246) | 0.174 | ||||
SLEDAI-2K | 1.134 (1.015–1.266) | 0.026 | 1.020 (0.872–1.195) | 0.801 | 1.074 (0.935–1.233) | 0.315 |